Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for HIV AIDS Clinical Trials
HIV AIDS clinical trials are recruiting across 82 cities. Here are the cities with the most active studies:
HIV AIDS Trial Phases
55 research organizations are sponsoring hiv aids trials.
About HIV AIDS
HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.
Clinical trials are advancing new treatments for hiv aids. Currently, 100 studies are recruiting a combined 286,001 participants across the United States. Research is being conducted by 55 organizations including Westat, Children's Hospital Medical Center, Cincinnati, Syneos Health and 52 others.
2026 HIV AIDS Research Landscape
As of August 2026, the hiv aids clinical trial landscape includes 100 actively recruiting studies across 82 cities in the United States. These studies are collectively seeking 286,001 participants, with an average enrollment target of 2,860 per study.
The research spans multiple phases of development: 63 studies are in NA, 7 studies are in PHASE3, 5 studies are in PHASE1, 5 studies are in PHASE2, 5 studies are in PHASE4. The presence of Phase 3 trials indicates that some hiv aids treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 55 different organizations, including Westat, Children's Hospital Medical Center, Cincinnati, Syneos Health, University of Miami, George Washington University, and 50 others. The large number of sponsors reflects significant research interest and investment in hiv aids treatment advancement.
Geographically, hiv aids trials are most concentrated in Miami, Florida (13 trials); Chicago, Illinois (12 trials); Baltimore, Maryland (11 trials); Bethesda, Maryland (10 trials); Los Angeles, California (8 trials) and 7 other cities.
Featured HIV AIDS Studies
Highlighted recruiting studies for hiv aids, selected by enrollment size and research scope.
Screen2Prevent (S2P)
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrE...
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
The goal of this interrupted time series quasi-experimental design study is to implement universal opt- out HIV testing and linkage to HIV preventive care in 15-21 year old adolescents visiting the pediatric emergency department (ED). The main question\[s\] it aims to answer are: 1. What is the uptake, reach and effectiveness of universally offered, opt-out HIV screening across pediatric EDs afte...
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
The purpose of the Antiretroviral Pregnancy Registry (Registry) is to detect any major teratogenic effect involving any of the Registry drugs when administered to pregnant people. Registration is voluntary and confidential with information obtained from the health care provider. A Registry-assigned identifier allows for follow-up capability. Information on subjects is provided to the Registry pros...
Frequently Asked Questions About HIV AIDS Clinical Trials
Are there hiv aids clinical trials near me?
Yes, there are 100 hiv aids clinical trials currently recruiting across 82+ cities in the United States, including Miami, Florida; Chicago, Illinois; Baltimore, Maryland. Browse the studies above to find one at a location convenient for you.
How do I join a hiv aids clinical trial?
To join a hiv aids clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are hiv aids clinical trials free?
Yes, participation in hiv aids clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of hiv aids treatments are being studied?
Current hiv aids clinical trials are testing a range of approaches across NA (63 studies), PHASE3 (7 studies), PHASE1 (5 studies), PHASE2 (5 studies), PHASE4 (5 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 55 research organizations.
Is it safe to participate in hiv aids clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated August 31, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated August 31, 2026 · Data from ClinicalTrials.gov